MedPath

Evaluation of Effect and Safety of 'RELUMINO-S'

Not Applicable
Completed
Conditions
Diseases of the eye and adnexa
Registration Number
KCT0006460
Lead Sponsor
Chung-Ang Univerisity Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
35
Inclusion Criteria

1.Patients who are 19 years old or older
2.Patients with low vision who are thought not to be able to correct with glasses, contact lenses and surgery
3.Patients with best-corrected visual acuity between 0.48 LogMAR and 1.3 LogMAR in the better eye
4.Vision has been stable for at least for 3 months before the screening

Exclusion Criteria

1.Patients who experienced intravitreal injection (ex. Anti-VEGF) or laser therapy within 6 months before the first screening
2.Patients who have disabilities other than low vision
3.Patients with orbital malformation or dermatological disease, unable to wear device
4.Alcohol abuse, drug abuse, mental illness, or significant systemic disease
5.Illiteracy who cannot read Korean

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath